Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reviewed 562 alopecia areata patients in Colombia, observing a higher prevalence in women and common use of steroid injections and topical minoxidil as treatments.

In this study, conducted at a single hospital from 2017 to 2020, researchers analyzed epidemiological factors, clinical patterns, and associated comorbidities in patients with clinically diagnosed alopecia areata using questionnaires, clinical examinations, and lab data. Results are not reported in the abstract.

This case study reports that carbimazole therapy led to significant hair regrowth and a drop in thyrotropin receptor antibody levels in an 11-year-old girl diagnosed with alopecia areata and Graves' disease.

This case report describes koebnerization-induced vitiligo in a woman following repeated eyebrow microblading, suggesting a link between the procedure and the phenomenon in susceptible individuals.

This review discusses the possible link between cosmeceuticals and frontal fibrosing alopecia but reports no conclusive findings; the authors stress further research on environmental triggers is needed.

In this study, oral tofacitinib treatment led to significant hair regrowth and changes in skin and blood biomarkers in a patient with alopecia areata.

In this study, late-onset alopecia areata in Israeli patients was predominantly observed in females with mild disease, showing a high rate of complete hair regrowth but frequent relapses.

This report describes five cases of bitemporal alopecia areata with frontal hairline involvement, detailing their management strategies and highlighting potential differential diagnoses, but does not present new clinical results.

This study reports a novel TRbeta gene mutation associated with resistance to thyroid hormone syndrome, which may contribute to various forms of alopecia in the affected family members.

This study suggests that diffuse alopecia areata initially involves an intense inflammatory attack during the anagen phase, progressing through different hair cycle stages with specific shedding patterns.

Most patients with alopecia areata in Syria are young adult males, often with patchy scalp hair loss.

This study describes the clinical profile of scalp alopecia areata among patients at a tertiary care hospital, finding it more common in males, particularly those aged 21-30, with sudden onset and often asymptomatic progression.

This study developed a pemphigus model in mice showing that anti-Desmocollin 3 and anti-Desmoglein 3 antibodies lead to more severe disease, suggesting diverse antigens contribute to varying human pemphigus phenotypes.

In this study, researchers developed a pemphigus mouse model expressing anti-Desmocollin 3 antibodies and found it mimicked atypical pemphigus with distinct pathological features compared to the standard Desmoglein 3 model.

This case report documents a successful treatment of alopecia areata using Ayurvedic management, suggesting that Ayurveda could help restore balance and promote hair regrowth in this autoimmune condition.

This case report describes the successful treatment of alopecia areata using Ayurvedic management, suggesting that Ayurveda may aid in rebalancing the body and promoting hair regrowth in autoimmune conditions.

This study found that anxiety disorders are relatively common among patients with hair loss, especially in women, highlighting the importance of comprehensive management including psychological support.

This study found that alopecia areata was more common in males, most frequently appeared on the scalp, and typically presented as patchy hair loss.

This case study reports successful treatment of alopecia areata in a 22-year-old woman using an Ayurvedic approach, including microneedling and herbal therapies, which improved her SALT score from 22% to 0% after one month.

This abstract provides background information on alopecia areata, describing it as an autoimmune condition leading to non-scarring, patchy hair loss but does not report specific study results.

This literature review reports that treatments for alopecia areata, including topical and intralesional corticosteroids, provide varied responses, and emphasizes the importance of supporting patients emotionally, given the limited and promising evidence of effectiveness for other treatments.

In this Baquba city study, alopecia areata was more prevalent among males aged 21 to 30, with most experiencing single lesions on the head, recurring cases, and a history of psychological stress.

Different types of alopecia in children require specific diagnoses and treatments.

This study found that among Chinese patients with alopecia areata, those with alopecia totalis/universalis had an earlier onset, longer duration, and more severe quality of life impact compared to those with patchy alopecia.

This study observed that Chinese patients with alopecia totalis or universalis had an earlier onset, longer duration, and more severe impact on quality of life compared to those with patchy alopecia areata.

This article presents a discussion on alopecia areata in infants and concludes that the condition's occurrence in this age group is not as rare as previously thought; it offers no new data.

This review discusses treatment approaches for alopecia areata, including promising novel therapies, and reports no new clinical results.

Korean medical treatments are effective for alopecia areata, especially in less severe cases.

This case report describes a 30-year-old woman with vitiligo who developed a rare dermatophyte infection encircling one of her vitiligo patches, possibly due to immunosuppression from her treatment.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.